Diseases, Conditions, Syndromes

Early-stage respiratory syncytial virus (RSV) vaccine trial begins

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched a clinical trial of an investigational vaccine designed to protect against respiratory syncytial ...

Diseases, Conditions, Syndromes

Crucial test of Ebola vaccine raises hopes, doubts in Congo

Irene Mboyo Mola spent 11 days caring for her husband as he died of Ebola in a hospital where she said nurses were too scared to get close. She helped him to the bathroom, picked up his feverish body when he lost his balance, ...

Diseases, Conditions, Syndromes

WHO reports new Ebola case in DR Congo, vaccine this week

The head of the World Health Organization said Sunday there has been another reported case of Ebola in the Democratic Republic of Congo and that an experimental vaccine to fight the disease is expected to become available ...

Diseases, Conditions, Syndromes

UN health agency: Hungarian scientist exposed to Ebola

The World Health Organization says it has coordinated shipment of an experimental Ebola vaccine and drugs to treat a laboratory scientist in Hungary who was exposed to the potentially deadly disease earlier this month.

Diseases, Conditions, Syndromes

H7N9 influenza vaccine clinical trials begin

Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States. The Phase 2 studies, sponsored by the National ...

Diseases, Conditions, Syndromes

Trials show inactivated Zika virus vaccine is safe and immunogenic

The investigational Zika purified inactivated virus (ZPIV) vaccine was well-tolerated and induced an immune response in participants, according to initial results from three Phase 1 clinical trials. Scientists at the Walter ...

Diseases, Conditions, Syndromes

Study clears important hurdle toward developing an HIV vaccine

An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation ...

page 8 from 18